The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function

被引:0
|
作者
Yisong Y Wan
Hongbo Chi
Min Xie
Michael D Schneider
Richard A Flavell
机构
[1] Section of Immunobiology,Center for Cardiovascular Development and Department of Medicine
[2] Yale University School of Medicine,undefined
[3] Baylor College of Medicine,undefined
[4] Howard Hughes Medical Institute,undefined
来源
Nature Immunology | 2006年 / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The kinase TAK1 is critical for innate and B cell immunity. The function of TAK1 in T cells is unclear, however. We show here that T cell–specific deletion of the gene encoding TAK1 resulted in reduced development of thymocytes, especially of regulatory T cells expressing the transcription factor Foxp3. In mature thymocytes, TAK1 was required for interleukin 7–mediated survival and T cell receptor–dependent activation of transcription factor NF-κB and the kinase Jnk. In effector T cells, TAK1 was dispensable for T cell receptor–dependent NF-κB activation and cytokine production, but was important for proliferation and activation of the kinase p38 in response to interleukins 2, 7 and 15. Thus, TAK1 is essential for the integration of T cell receptor and cytokine signals to regulate the development, survival and function of T cells.
引用
收藏
页码:851 / 858
页数:7
相关论文
共 50 条
  • [41] Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol
    Jiang, ZF
    Jun, NT
    Qian, YC
    Matsumoto, K
    Li, XX
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (20) : 7158 - 7167
  • [42] PERK Integrates Oncogenic Signaling and Cell Survival During Cancer Development
    Bu, Yiwen
    Diehl, J. Alan
    JOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (10) : 2088 - 2096
  • [43] TAK1 MAPK kinase kinase mediates transforming growth factor-β signaling by targeting SnoN oncoprotein for degradation
    Kajino, Taisuke
    Omori, Emily
    Ishii, Shunsuke
    Matsumoto, Kunihiro
    Ninomiya-Tsuji, Jun
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (13) : 9475 - 9481
  • [44] The Contribution of Toll-Like Receptor Signaling to the Development of Hepatic Fibrosis and Carcinogenesis in Hepatocyte Specific TAK1 Deleted Mice
    Song, Jingyi
    Inokuchi, Sayaka
    Roh, Yoonseok
    Yang, Ling
    Seki, Ekihiro
    HEPATOLOGY, 2013, 58 : 322A - 323A
  • [45] TAK1 is activated by TGF-β signaling and controls axonal growth during brain development
    Yu, Jingwen
    Zhang, Feng
    Wang, Shuo
    Zhang, Yongqing
    Fan, Ming
    Xu, Zhiheng
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2014, 6 (04) : 349 - 351
  • [46] Enterocyte-derived TAK1 signaling prevents epithelium apoptosis and the development of ileitis and colitis
    Kajino-Sakamoto, Rie
    Inagaki, Maiko
    Lippert, Elisabeth
    Akira, Shizuo
    Robine, Sylvie
    Matsumoto, Kunihiro
    Jobin, Christian
    Ninomiya-Tsuji, Jun
    JOURNAL OF IMMUNOLOGY, 2008, 181 (02): : 1143 - 1152
  • [47] Expression of TAK1, a mediator of TGF-β and BMP signaling, during mouse embryonic development
    Jadrich, JL
    O'Connor, MB
    Coucouvanis, E
    GENE EXPRESSION PATTERNS, 2003, 3 (02) : 131 - 134
  • [48] Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling
    He, W.
    Cronstein, B. N.
    PURINERGIC SIGNALLING, 2012, 8 (02) : 327 - 337
  • [49] Protein kinase D2 integrates antigen receptor, diacylglycerol and Protein Kinase C mediated signals to fine tune cytokine production in T cells
    Navarro, M. N.
    Feijoo-Carnero, C.
    Sinclair, L. V.
    Martin, D.
    Goebel, J.
    Cantrell, D. A.
    IMMUNOLOGY, 2012, 137 : 378 - 378
  • [50] Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses
    Reiley, William W.
    Jin, Wei
    Lee, Andrew Joon
    Wright, Ato
    Wu, Xuefeng
    Tewalt, Eric F.
    Leonard, Timothy O.
    Norbury, Christopher C.
    Fitzpatrick, Leo
    Zhang, Minying
    Sun, Shao-Cong
    JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (06): : 1475 - 1485